Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
Clinical trial NCT06066424 · RECRUITING
Trial details
- NCT number
- NCT06066424
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-24
- Primary completion
- 2038-04-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.